The Clorox Company (CLX) Stock Forecast & Price Target
The Clorox Company · NYSE
$100.34+2.93 (+3.01%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 13 firms covering The Clorox Company, 0 rate it Buy or better, 9 sit at Hold, and 4 rate it Sell or worse, a moderate sell consensus. Targets are tightly clustered, $86.00 to $110.00, so the covering firms are broadly aligned. The average target of $97.83 sits 2% below the current $100.34. The rating mix has stayed broadly stable, with Buy-side ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.21 next quarter toward $5.99 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 ratings
Moderate Sell
Strong Buy00%
Buy00%
Hold969%
Sell431%
Strong Sell00%
Based on 13 analysts giving stock ratings to The Clorox Company.
As of Jul, 0 of 13 firms rate CLX a Buy (9 Hold, 4 Sell), the standing distribution of every covering firm's most recent active call.
CLX EPS & revenue forecast
EPS · NEXT QUARTER
$1.21
Range $0.91 – $1.44 · 11 analysts · +42% YoY
Next period, 11 analysts expect The Clorox Company to earn $1.21 a share (range $0.91 – $1.44), versus $0.85 a year earlier. , growing to $5.99 the year after.
REVENUE · NEXT QUARTER
$1.8B
Range $1.8B – $1.9B · 11 analysts · +29% YoY
Revenue is expected to reach $1.8B (range $1.8B – $1.9B), +28.8% year-over-year., rising to $7.6B next year.
Top analysts covering The Clorox Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CLX.
#1
Lauren Lieberman
Barclays · Rank #207
Sell
$86.00-14.3% to target
Overall win rate
43%
+ Follow
#2
Peter Grom
UBS
Hold
$100.00-0.3% to target
Coverage
—
+ Follow
#3
Chris Carey
Wells Fargo
Hold
$95.00-5.3% to target
Coverage
—
+ Follow
#4
Filippo Falorni
Citigroup
Hold
$97.00-3.3% to target
Coverage
—
+ Follow
#5
Andrea Teixeira
JP Morgan
Sell
$92.00-8.3% to target
Coverage
—
+ Follow
CLX stock forecast FAQ
What is CLX's average 12-month price target?+
The 12 analysts with a live target average $97.83 for The Clorox Company over the next 12 months, ranging from a $110.00 high to a $86.00 low.
Is CLX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Sell. Of the 13 analyst ratings, 0 are Buy or Strong Buy, 9 are Hold, and 4 are Sell or Strong Sell.
What are the highest and lowest price targets for CLX?+
The Street-high target is $110.00 (Morgan Stanley), and the Street-low is $86.00 (Barclays). The average of all 12 active targets is $97.83.
How many Wall Street analysts cover CLX?+
13 analysts have an active rating on The Clorox Company, and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering CLX?+
Among analysts who currently cover CLX, Lauren Lieberman of Barclays has the strongest overall Quantellect track record (Rank #207). Their current call is Sell with a $86.00 target.
What is The Clorox Company's projected EPS for next quarter?+
The consensus estimate is $1.21 per share (range $0.91 – $1.44) across 11 analysts, rising to $5.99 the following year.
How much revenue is The Clorox Company expected to report next quarter?+
Consensus revenue is $1.8B (range $1.8B – $1.9B), growing to $7.6B next year.
Have analysts been upgrading or downgrading CLX lately?+
As of Jul, 0 of 13 firms rate CLX a Buy (9 Hold, 4 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CLX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
